Aberrant Promoter Methylation of CDH13 and MGMT Genes is Associated With Clinicopathologic Characteristics of Primary Non–Small-Cell Lung Carcinoma

Clinical Lung Cancer - Tập 13 - Trang 297-303 - 2012
Milica Kontic1, Jelena Stojsic2, Dragana Jovanovic1, Vera Bunjevacki3, Simona Ognjanovic4, Jacquelyn Kuriger5, Susan Puumala6, Heather H. Nelson7
1Pulmonology Clinic, Clinical Centre of Serbia, Medical Faculty, University in Belgrade, Belgrade, Serbia
2Pathology Department, Pulmonology Clinic, Clinical Centre of Serbia, Medical Faculty, University in Belgrade, Belgrade, Serbia
3Oncogenetics Department, Institute for Human Genetics, Medical Faculty, University in Belgrade, Belgrade, Serbia
4Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota, MN
5Division of Epidemiology, Masonic Cancer Center, University of Minnesota, Minneapolis, MN
6Sanford Research/Sanford School of Medicine of the University of South Dakota, Sioux Falls, SD
7Division of Epidemiology and Community Health, Masonic Cancer Center, University of Minnesota, Minneapolis, MN

Tài liệu tham khảo

Saito, 2010, Long interspersed nuclear element 1 hypomethylation is a marker of poor prognosis in stage IA non–small cell lung cancer, Clin Cancer Res, 16, 2418, 10.1158/1078-0432.CCR-09-2819

Brock, 2008, DNA methylation markers and early recurrence in stage I lung cancer, N Engl J Med, 358, 1118, 10.1056/NEJMoa0706550

Vaissière, 2009, Quantitative analysis of DNA methylation profiles in lung cancer identifies aberrant DNA methylation of specific genes and its association with gender and cancer risk factors, Cancer Res, 69, 243, 10.1158/0008-5472.CAN-08-2489